Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers
| Errataetall: |
CommentOn: J Infect. 2021 May;82(5):162-169. - PMID 33766553 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:83 |
|---|---|
| Enthalten in: |
The Journal of infection - 83(2021), 2 vom: 30. Aug., Seite 237-279 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tré-Hardy, Marie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Neutralizing |
|---|
| Anmerkungen: |
Date Completed 30.07.2021 Date Revised 31.08.2021 published: Print-Electronic CommentOn: J Infect. 2021 May;82(5):162-169. - PMID 33766553 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.03.025 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM323674143 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM323674143 | ||
| 003 | DE-627 | ||
| 005 | 20231225184704.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.03.025 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1078.xml |
| 035 | |a (DE-627)NLM323674143 | ||
| 035 | |a (NLM)33811939 | ||
| 035 | |a (PII)S0163-4453(21)00158-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tré-Hardy, Marie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Reactogenicity, safety and antibody response, after one and two doses of mRNA-1273 in seronegative and seropositive healthcare workers |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.07.2021 | ||
| 500 | |a Date Revised 31.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Infect. 2021 May;82(5):162-169. - PMID 33766553 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Immunogenicity, Reactogenicity, Safety, mRNA-1273 vaccine | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 650 | 7 | |a RNA, Messenger |2 NLM | |
| 700 | 1 | |a Cupaiolo, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Papleux, Emmanuelle |e verfasserin |4 aut | |
| 700 | 1 | |a Wilmet, Alain |e verfasserin |4 aut | |
| 700 | 1 | |a Horeanga, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Antoine-Moussiaux, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Della Vecchia, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Beukinga, Ingrid |e verfasserin |4 aut | |
| 700 | 1 | |a Vekemans, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Blairon, Laurent |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 83(2021), 2 vom: 30. Aug., Seite 237-279 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:83 |g year:2021 |g number:2 |g day:30 |g month:08 |g pages:237-279 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.03.025 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 83 |j 2021 |e 2 |b 30 |c 08 |h 237-279 | ||